psoriatic arthritis

Zasocitinib shows promise in psoriatic arthritis phase 2b trial

Risankizumab added to PBS for psoriatic arthritis

‘Gender-blinded’ approach to PsA needs to change

Anti-JAKs safe in skin conditions

Psoriasis management resources to empower your patients

Hey PRESTO! There’s the PsA

IL-23 inhibitors for psoriasis best at preventing arthritis development

One size does not fit all
